Navigation Links
Research shows aerobic exercise combined with resistance training improves glucose control in diabetics
Date:10/31/2008

.dtl">www.ptjournal.org/misc/podcasts.dtl. The podcast highlights PTJ's Diabetes Special Issue: "People With Diabetes: A Population Desperate for Movement." (November 2008). Marcus and other experts discuss new information about the roles of fat in people with diabetes, especially fat in muscle, and about how this fat appears to impair muscle function. Running time: 24:29 (11,487 KB).

Paul LaStayo, PT, PhD, the study's senior author, notes that the eccentric resistance exercise program was specifically designed to increase strength and muscle size, using a recumbent stepper that produced a lengthening contraction, such as when lowering the dumbbell in a bicep curl.

After 3 months, Marcus and LaStayo found that both groups showed improved glucose control and physical performance in a 6-minute walk, as well as a decrease in fat composition within the leg muscles. "This study is particularly interesting because the patients who did both aerobic and resistance exercise had additional improvements, most notably a decreased overall BMI and a gain in leg muscle," Marcus said.

"Although aerobic exercise is still key in treating diabetes, it should not be used in isolation," Marcus observes. "As people age, they lose muscle mass and, subsequently, mobility, resulting in a greater risk of falls. Adding resistance training to the diabetes treatment regimen leads to improved thigh lean tissue which, in turn, may be an important way for patients to increase resting metabolic rate, protein reserve, exercise tolerance, and functional mobility, she notes.

This study is part of PTJ's special issue on diabetes, which illustrates that physical therapy interventions can have a dramatic and positive effect in fighting the complications associated with diabetes. As the movement experts, physical therapists are ideally suited to help this population safely and to effectively address their movement dysfunctions.


'/>"/>

Contact: Jennifer Rondon
jenniferrondon@apta.org
American Physical Therapy Association
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Research Shows That Combining Aerobic Exercise With High-Force Eccentric Resistance Training Improves Glucose Control in Diabetes Patients
2. Opt out system could solve donor organ shortage, says researcher
3. Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows
4. Halpin Foundation and the ASN announce recipient of Halpin Foundation-ASN research grant
5. International Society for Stem Cell Research Highlights New YouTube Channel Providing Accurate Scientific Perspectives on Stem Cell Research
6. Weill Cornell Medical College receives 2 $100,000 grants for innovative global health research
7. HealthMetrix Research Selects 2009 Medicare Advantage Plans for Best Overall Benefit Value
8. Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis
9. Cancer requires support from immune system to develop, UT Southwestern researchers report
10. Research Reveals Why Tamoxifen Doesnt Always Work
11. National grants further WA Medical Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...arkett Sports, the worldwide leader in sports surf...offering with a more complete and innovative range...sports flooring experts and the launch of www.tar...(PRWEB) November 9, 2009 -- Tarkett Sports, redesi... products includes hardwood and synthetic basketba...
(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Mindray Medi...developer, manufacturer and,marketer of medical de...dited,financial results for the third quarter and ...lights for Operations as of September 30, 2009, ...llion, an increase of, 3.1% over the third q...
(Date:11/9/2009)...RNewswire/ -- The Churchill Centre today announc...p to J.W. "Bill" Marriott for his lifelong commitm...e market practices and fostering an open and trans...receive his award at a ceremony and dinner on Tues...ns Hotel. ,, "This is a testament to how Bill ...
(Date:11/9/2009)...nlargement, study finds , , MONDAY, Nov....tor for left atrial enlargement, which increases t...a new study shows. , Atrial fibrillation is the...t rhythm or heartbeat). , Researchers analyzed...rmany who were followed for 10 years. The study au...
(Date:11/9/2009)...t both eye conditions are age-related, researchers... -- Cataract surgery doesn,t appear to speed the p...D), according to a new study that challenges the b...ns the other. , "Because both conditions are st... also have AMD," wrote Li Ming Dong, of Stony Broo...
Breaking Medicine News(10 mins):Health News:Tarkett Sports Launches Revamped Indoor Sports Flooring Division and New Indoor Website 2Health News:Mindray Announces Third Quarter 2009 Financial Results 2Health News:Mindray Announces Third Quarter 2009 Financial Results 3Health News:Mindray Announces Third Quarter 2009 Financial Results 4Health News:Mindray Announces Third Quarter 2009 Financial Results 5Health News:Mindray Announces Third Quarter 2009 Financial Results 6Health News:Mindray Announces Third Quarter 2009 Financial Results 7Health News:Mindray Announces Third Quarter 2009 Financial Results 8Health News:Mindray Announces Third Quarter 2009 Financial Results 9Health News:Mindray Announces Third Quarter 2009 Financial Results 10Health News:Mindray Announces Third Quarter 2009 Financial Results 11Health News:Mindray Announces Third Quarter 2009 Financial Results 12Health News:Mindray Announces Third Quarter 2009 Financial Results 13Health News:Mindray Announces Third Quarter 2009 Financial Results 14Health News:Mindray Announces Third Quarter 2009 Financial Results 15Health News:Mindray Announces Third Quarter 2009 Financial Results 16Health News:Mindray Announces Third Quarter 2009 Financial Results 17Health News:Mindray Announces Third Quarter 2009 Financial Results 18Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2
...visor and speaker Michael Morgan is helping U.S., ...d Middle Eastern and Islamic investors, business, ...ts tap into one of the most active investment sour...ities for everyone to find new markets, partners a...
...HO: Myles Druckman, MD, a leading disease outbr... Dr. Druckman has been interviewed by, ... CNN, CNBC, and, The Washington Post, a... including:, * The WHO raising ...
...r. Joel Selanikio,s innovative technology is not o...ublic health system around the world. Merging his ...ne and public health with his business partner,s b...lth data in developing nations. Officially establi...
...Biosystems, Inc. (OTC Bulletin Board: WGBS), a lea...s systems, today announced the signing of a resear...nter scientists for WaferGen,s SmartChip(TM) Real-... for Genome Sciences and Policy at Duke Universit...
...n and Narrows Earnings Guidance to Upper End of Ra...Hospira, Inc. (NYSE: HSP ), a leading global spe...any, today reported results for the first quarter ...rtain specified items as described later in this p...
...Associates Outlines China ,s , Stimulus Plan a... has announced a $124 billion stimulus package t... calls for digital hospitalization, adoption of el...tual healthcare services that can help overcome di...
Other Medicine News:Health News:Global Advisor and Speaker Explains Middle East Investors, Politics, Culture 2Health News:Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu 2Health News:Available for Interviews: Pandemic, Disease Outbreak Expert to Discuss Swine Flu 3Health News:Open source mobile technology software reinventing health care in developing countries 2Health News:Open source mobile technology software reinventing health care in developing countries 3Health News:Open source mobile technology software reinventing health care in developing countries 4Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 2Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 3Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 4Health News:WaferGen and Leading Academic Medical Center Establish Genotyping Research Collaboration to Validate SNPs in Breast Cancer Using SmartChip(TM) Real-Time PCR System 5Health News:Hospira Reports First-Quarter 2009 Results 2Health News:Hospira Reports First-Quarter 2009 Results 3Health News:Hospira Reports First-Quarter 2009 Results 4Health News:Hospira Reports First-Quarter 2009 Results 5Health News:Hospira Reports First-Quarter 2009 Results 6Health News:Hospira Reports First-Quarter 2009 Results 7Health News:Hospira Reports First-Quarter 2009 Results 8Health News:Hospira Reports First-Quarter 2009 Results 9Health News:Hospira Reports First-Quarter 2009 Results 10Health News:Hospira Reports First-Quarter 2009 Results 11Health News:Hospira Reports First-Quarter 2009 Results 12Health News:Hospira Reports First-Quarter 2009 Results 13Health News:Hospira Reports First-Quarter 2009 Results 14Health News:Hospira Reports First-Quarter 2009 Results 15Health News:Hospira Reports First-Quarter 2009 Results 16Health News:Hospira Reports First-Quarter 2009 Results 17Health News:Hospira Reports First-Quarter 2009 Results 18Health News:China Seeks to Transform Healthcare Sector with Information Technology 2
(Date:11/9/2009)...ov. 9 ISTA Pharmaceutica...nal results from the Company,s Bepreve(TM) (bepota...linical studies. These results were presented in ...American College of Allergy, Asthma & Immunolo...presentation titled, "Treatment of Ocular Itching ...
(Date:11/9/2009)... Mass., Nov. 9 Decision Resources,...firms for pharmaceutical and healthcare issues, fi...eceptor 2 (HER2) targeting therapies -- which incl...ippon Kayaku,s Tykerb/Tyverb -- were the highest-s...inued uptake of Herceptin and Tykerb/Tyverb and th...
(Date:11/9/2009)...PHIA, Nov. 9 Shire plc...ty biopharmaceutical company, today announced the ...ded Release Tablets in pharmacies across the Unite...peractivity Disorder ( ADHD ) in children and ad...mulation of guanfacine, is the first and only nons...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Sales of HER2-Targeting Agents for Breast Cancer, Including Herceptin and Tykerb/Tyverb, Will Grow by 3.3 Percent Annually from 2008 to 2018 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 1BCBSF to Cover the Administration of H1N1 Vaccination for All Members 57166 2Research Councils UK sign groundbreaking MoU with Brazil 9928 1Research Councils UK sign groundbreaking MoU with Brazil 9928 2Research Councils UK sign groundbreaking MoU with Brazil 9928 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 1BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 2BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 3BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 4BioCryst Announces Partnerships for Peramivir for Influenza Outside the U S 57160 5
...y 15 Cytopia Limited,(ASX: CYT) today announced t...n on CYT997 at the 2008 Annual Meeting of the Amer...ccessible to the public via ASCO,s,website (http:...DT)., The oral presentation, entitled "Phase I ev... disrupting agent, in patients with advanced cance...
... Schering-Plough,Corporation (NYSE: SGP ), a lea...nic hepatitis C virus (HCV) infection, announced t...PEGINTRON(TM) (peginterferon alfa-2b) and,REBETOL(...s boceprevir, the,company,s investigational oral H...th annual Digestive Disease Week (DDW) meeting to ...
Other Medicine Technology:Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7
FemoStop
VasoSeal VHD KIT 6
VasoSeal VHD KIT 4
Hemapatch Knitted
Medicine Products: